Krishna Institute of Medical Sciences Limited has announced a conference call for analysts and investors, scheduled for Monday, May 18, 2026, at 9:30 am IST. The call, hosted by IIFL Capital, will focus on the company's business strategy and outlook following the declaration of its Q4FY26 financial results. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The earnings conference call will bring together key members of the company's senior leadership to engage with the investment community. The following table summarises the key details of the event:

Management Participants

The conference call will feature participation from the following senior executives of Krishna Institute of Medical Sciences:

• Dr. Bhaskara Rao Bollineni – Founder & Managing Director
• Dr. Abhinay Bollineni – Executive Director & CEO
• Mr. Sachin Salvi – Chief Financial Officer

Regulatory Disclosure

The intimation was filed by Nagajayanthi J R, Company Secretary & Compliance Officer of Krishna Institute of Medical Sciences Limited, on May 12, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The conference call is accessible to international participants across multiple time zones, with the event corresponding to 12:00 pm in Hong Kong and Singapore, 5:00 am in the UK, and 12:00 am ET in the USA.

Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has entered into a long-term lease agreement for 2 acres of land in Amaravati, Andhra Pradesh, for a period of 60 years. The agreement has been executed with the Andhra Pradesh Capital Region Development Authority (APCRDA) and was disclosed to stock exchanges on 8th May, 2026, as a material event.

Key Details of the Lease Agreement

The following table outlines the key parameters of the lease agreement as disclosed by the company:

Proposed Hospital and Specialties

The proposed facility is described as a state-of-the-art 500-bedded multi-speciality hospital that will offer comprehensive tertiary and quaternary care. The hospital is planned to cover a wide range of medical specialties, as detailed below:

• Cardiology
• Oncology
• Neurosciences
• Gastroenterology
• Orthopaedics
• Mother & Child Care
• Critical Care
• Organ Transplant
• Other key specialties

Healthcare Access in the Region

According to the company's disclosure, the proposed hospital aims to address a long-standing need for advanced healthcare infrastructure in the Amaravati region. The facility is expected to provide patients in Amaravati and surrounding districts of Andhra Pradesh with access to high-end clinical capabilities, reducing the need to travel to other metros for specialized medical care.

The disclosure was signed by Nagajayanthi J. R., Company Secretary and Compliance Officer of Krishna Institute of Medical Sciences Limited, and was submitted to both BSE and NSE on 8th May, 2026.